Current Portfolio Allocation for Core Biotech1. Selling my stake in Abcellera Biologics (ABCL) for 18% loss2. Adding to my position in Axsome Therapeutics (AXSM), increasing portfolio weighting from 4 ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

As CDMO giants Wuxi AppTec and WuXi Biologics come under mounting scrutiny for their alleged ties to Chinese government officials, they are losing a key ally in Washington, D.C. Wednesday, the ...

Add Yahoo as a preferred source to see more of our stories on Google. A professional in the event planning division of an international biotechnology trade group is running as a Democrat for the ...

Shortly after the arrival of a permanent successor following more than a year under interim CEO Rachel King, the top U.S. biotechnology trade group has bid adieu to its lobbying head. “We can confirm ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

X4 Pharmaceuticals is rated BUY, driven by a funded Phase 3 trial, current product pipeline, and a strong cash position extending into 2028. XFOR's primary value lies in its 4WARD Phase 3 trial in ...

Later this month, BIO will hold its annual conference. BIO provides advocacy, business development, and communications services for its members worldwide. BIO came into existence in 1993 through the ...

BIO, the world’s largest trade group for the biotechnology industry, has gone from trying to water down proposed US legislation to sever ties with Chinese health care companies, to supporting it.

On April 20, 2023 at 09:35:36 ET an unusually large $999.05K block of Call contracts in Legend Biotech Corp – ADR (LEGN) was sold, with a strike price of $75.00 / share, expiring in 211 day(s) (on ...